Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, has announced a new distribution agreement with Germany-based Axel Semrau
The agreement covers sales of Eksigent's NanoLC and ExpressLC HPLC product lines in Germany, Switzerland, Austria and Benelux.
Axel Semrau supplies instruments, systems and automated solutions to researchers in drug discovery, quality control and general laboratory applications.
The company's bioanalytical/liquid chromatography business division, in which the Eksigent products will be handled, markets a range of chromatography, LC/MS, autosampling and high-throughput screening systems.
This division serves drug development from synthesis to quality control, pharmacokinetics and proteomics research.
Another Axel Semrau division supports gas chromatography and GC/MS.
"Eksigent is well-positioned to serve the European academic, biotech and pharmaceutical markets and Axel Semrau is a strong distribution partner for us," commented David Weber, Eksigent's president and CEO.
"Their existing portfolio of offerings and solid customer relationships make them an excellent fit for us".
"The outstanding nano- and micro-HPLC product range from Eksigent is a perfect fit with our strategic vision," commented Norbert Wenkel, managing director of Axel Semrau.
"Our sales network and high-quality customer service and support will enable us to penetrate new markets with the Eksigent products".
Eksigent is a pioneer in low-flow fluid delivery systems that automate and accelerate proteomics, drug discovery, drug delivery and other life science applications.
Eksigent's core technologies include microscale pumping, microfluidic system design and microfabrication.
The company offers solutions for nanoscale liquid chromatography, high-performance capillary liquid chromatography and drug delivery.
